Open AccessP755: HYPERFERRITINEMIA IS A PREDICTIVE BIOMARKER OF POOR CLINICAL OUTCOMES IN CMML
Author(s) -
Aguirre L. E.,
Ball S.,
Jain A.,
Al Ali N.,
Sallman D.,
Kuykendall A.,
Sweet K.,
Lancet J.,
Padron E.,
Komrokji R.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845904.69112.ee
Subject(s) - medicine , biomarker , ferritin , myeloid , proportional hazards model , disease , cancer , oncology , gastroenterology , immunology , biology , biochemistry